Csenge Advisory Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,192
| Closed | -$200K | – | 664 |
|
|
2023
Q3 | $200K | Sell |
7,192
-141
| -2% | -$3.93K | 0.01% | 593 |
|
|
2023
Q2 | $250K | Sell |
7,333
-2,530
| -26% | -$86.2K | 0.02% | 545 |
|
|
2023
Q1 | $297K | Sell |
9,863
-1,637
| -14% | -$49.2K | 0.02% | 474 |
|
|
2022
Q4 | $325K | Buy |
11,500
+656
| +6% | +$18.5K | 0.03% | 444 |
|
|
2022
Q3 | $356K | Sell |
10,844
-44
| -0.4% | -$1.44K | 0.03% | 413 |
|
|
2022
Q2 | $343K | Sell |
10,888
-1,274
| -10% | -$40.1K | 0.03% | 419 |
|
|
2022
Q1 | $559K | Sell |
12,162
-13,392
| -52% | -$616K | 0.04% | 355 |
|
|
2021
Q4 | $2.37M | Sell |
25,554
-198
| -0.8% | -$18.4K | 0.21% | 90 |
|
|
2021
Q3 | $1.93M | Buy |
25,752
+198
| +0.8% | +$14.8K | 0.16% | 109 |
|
|
2021
Q2 | $2.37M | Sell |
25,554
-4,836
| -16% | -$449K | 0.21% | 90 |
|
|
2021
Q1 | $2.67M | Buy |
30,390
+8,485
| +39% | +$744K | 0.27% | 73 |
|
|
2020
Q4 | $2.04M | Buy |
21,905
+1,855
| +9% | +$173K | 0.24% | 76 |
|
|
2020
Q3 | $1.35M | Buy |
+20,050
| New | +$1.35M | 0.18% | 91 |
|